Results 301 to 310 of about 1,316,710 (378)

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

Central blood pressure and arterial stiffness among ultramarathon runners across the lifespan. [PDF]

Eur J Appl Physiol
Vondrasek JD, Jeong S, El-Kurd OB, Linder BA, Stute NL, Domeier C, Bissen TG, Bagley JR, Robinson AT, Babcock MC, Grosicki GJ, Watso JC.   +11 more
europepmc   +1 more source

Arterial stiffness in predialysis patients with uremia

, 2004
Kayo Shinohara, Tetsuo Shoji, Yoshihiro Tsujimoto, Eiji Kimoto, Hideki Tahara, Hidenori Koyama, Masanori Emoto, Eiji Ishimura, Takami Miki, Tsutomu Tabata, Yoshiki Nishizawà   +10 more
openalex   +1 more source

Cardiovascular toxicity induced by TKIs in patients with chronic myeloid leukaemia: Are women and men different?

ESC Heart Failure, Volume 12, Issue 2, Page 1447-1454, April 2025.
This study analyzes 148 patients (66 women and 82 men) with chronic myeloid leukemia treated with tyrosine kinase inhibitors, focusing on cardiovascular adverse events. The risk assessment, performed using the HFA/ICOS score, reveals sex‐specific differences: venous thrombosis is more common in women, while arterial thrombosis predominates in men.
Cristina Madaudo, Daniela Di Lisi, Antonio Cannatà, Federica Manfrè, Celeste Vullo, Marco Santoro, Ciro Botta, Salvatrice Mancuso, Sergio Siragusa, Alfredo Ruggero Galassi, Giuseppina Novo   +10 more
wiley   +1 more source

Phenotype characterization of heart failure with preserved ejection fraction in medical device and surgical trials

ESC Heart Failure, EarlyView.
This systematic review identified 24 clinical trials of medical device and surgical interventions for HFpEF, with 16 demonstrating at least safety and feasibility, but little evidence of long‐term benefit. Phenotype‐based responses suggest that certain interventions may benefit specific HFpEF subgroups, yet most trials suffered from heterogeneous ...
Kurdo Araz, Francesco Fioretti, Sara Ladak, Mohammed Obaidan, Javed Butler, Aamir Hameed   +5 more
wiley   +1 more source

Non-Invasive Estimation of Arterial Stiffness Using Photoplethysmography Sensors: An In Vitro Approach. [PDF]

Sensors (Basel)
Diana G, Scardulla F, Puleo S, Pasta S, D'Acquisto L.   +4 more
europepmc   +1 more source

First evaluation of a novel pulsatile LVAD: Feasibility and haemodynamic impact in acute heart failure

ESC Heart Failure, EarlyView.
The pulsatile ventricular assist platform (pVAP) was connected to a membrane pump in six large swine models. The system, driven by a conventional intra‐aortic balloon pump console (IABP), was utilized to drain left atrial blood during systole and to eject the collected blood back into the ascending aorta during diastole.
Sara Knigge, Marcelo B. Bastos, Bastian Schmack, Liam Schana, Oren Malchin, Ali S. Merzah, Aron F. Popov, Alexander Weymann, Arjang Ruhparwar, Felix Schumacher, Günes Dogan, Jan D. Schmitto   +11 more
wiley   +1 more source

Evaluating the Acute Effects of Energy Drink Consumption on Arterial Stiffness in Healthy Young Adults. [PDF]

Anatol J Cardiol
Yaşar S, Geneş M, Eravcı Ö, Arslan A, Şirin H, Görmel S, Fırtına S, Karpat MS, Barçın C, Çelik M.   +9 more
europepmc   +1 more source

Is arterial stiffness a contributing factor to atrial fibrillation in patients with hypertension? A preliminary investigation

, 2004
James A. Reiffel
openalex   +1 more source

Percutaneous endocardial alginate–hydrogel injection in the treatment of heart failure: First‐in‐human study

ESC Heart Failure, EarlyView.
Using EndoWings™ and XDROP™, we developed a percutaneous minimally invasive technique for sequential circumferential alginate hydrogel injection into LV free mid‐wall. This human study assessed its safety/feasibility in HFrEF patients, with personalised biomechanical models.
Bo Wang, Shuo Wang, Chao Gao, D. Scott Lim, Rutao Wang, Xin Meng, Ying Liu, Cun‐jun Zhu, Yoshinobu Onuma, Yunbing Wang, Patrick W.J.C. Serruys, Runlin Gao, Randall J. Lee, Ling Tao   +13 more
wiley   +1 more source